Table 4. Associations with intentions to receive a Monkeypox vaccine, if recommended.
Odds Ratio (95% CI) | p-value | Adjusted* Odds Ratio (95% CI) | p-value | |
---|---|---|---|---|
Self-assessed knowledge | ||||
Poor / very poor | Reference | Reference | ||
Average | 1.2 (0.8–1.7) | 0.373 | 1.1 (0.7–1.8) | 0.701 |
Good / very good | 1.9 (1.2–2.9) | 0.005 | 2.1 (1.1–4.0) | 0.023 |
Self-efficacy | ||||
No self-efficacy | Reference | Reference | ||
Neutral | 0.8 (0.4–1.5) | 0.482 | 0.9 (0.3–2.4) | 0.837 |
Self-efficacy | 1.2 (0.7–2.) | 0.536 | 0.7 (0.3–1.9) | 0.487 |
Risk Perception | 1.9 (1.5–2.3) | <0.001 | 2.6 (1.8–3.6) | <0.001 |
Perceived exaggeration | ||||
No exaggeration | Reference | Reference | ||
Neutral | 0.3 (0.2–0.4) | <0.001 | 0.4 (0.3–0.7) | 0.002 |
Exaggeration | 0.4 (0.3–0.6) | <0.001 | 0.4 (0.2–0.7) | 0.002 |
Vaccine Trust Indicator | ||||
Low | 0.1 (0.0–0.3) | <0.001 | 0.3 (0.1–0.8) | 0.018 |
Medium | Reference | Reference | ||
High | 6.8 (4.6–10.1) | <0.001 | 5.4 (3.2–9.1) | <0.001 |
COVID-19 Vaccination Status | ||||
Not vaccinated | Reference | Reference | ||
Vaccinated | 29.6 (15.7–55.9) | <0.001 | 29.2 (13.1–65.3) | <0.001 |
Gender | ||||
Male | Reference | |||
Female | 0.4 (0.3–0.6) | <0.001 | 0.5 (0.3–0.8) | 0.003 |
*Adjusted for: all other variables in the table, age, education, race, ethnicity, survey weights
CI = Confidence Interval